These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17108190)

  • 21. Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.
    Apostolaki S; Perraki M; Kallergi G; Kafousi M; Papadopoulos S; Kotsakis A; Pallis A; Xenidis N; Kalmanti L; Kalbakis K; Agelaki S; Kalykaki A; Stournaras C; Stathopoulos E; Georgoulias V; Mavroudis D
    Breast Cancer Res Treat; 2009 Oct; 117(3):525-34. PubMed ID: 19016323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.
    Xenidis N; Ignatiadis M; Apostolaki S; Perraki M; Kalbakis K; Agelaki S; Stathopoulos EN; Chlouverakis G; Lianidou E; Kakolyris S; Georgoulias V; Mavroudis D
    J Clin Oncol; 2009 May; 27(13):2177-84. PubMed ID: 19332733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.
    Marques AR; Teixeira E; Diamond J; Correia H; Santos S; Neto L; Ribeiro M; Miranda A; Passos-Coelho JL
    Breast Cancer Res Treat; 2009 Mar; 114(2):223-32. PubMed ID: 18409061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a novel assay to quantify serum human telomerase reverse transcriptase messenger RNA and its significance as a tumor marker for hepatocellular carcinoma.
    Miura N; Maruyama S; Oyama K; Horie Y; Kohno M; Noma E; Sakaguchi S; Nagashima M; Kudo M; Kishimoto Y; Kawasaki H; Hasegawa J; Shiota G
    Oncology; 2007; 72 Suppl 1():45-51. PubMed ID: 18087181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transrenal nucleic acids: from proof of principle to clinical tests.
    Melkonyan HS; Feaver WJ; Meyer E; Scheinker V; Shekhtman EM; Xin Z; Umansky SR
    Ann N Y Acad Sci; 2008 Aug; 1137():73-81. PubMed ID: 18837928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does the presence of circulating tumor cells in the venous drainage of curative colorectal cancer resections determine prognosis? A meta-analysis.
    Katsuno H; Zacharakis E; Aziz O; Rao C; Deeba S; Paraskeva P; Ziprin P; Athanasiou T; Darzi A
    Ann Surg Oncol; 2008 Nov; 15(11):3083-91. PubMed ID: 18787906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating DNA. Its origin and fluctuation.
    van der Vaart M; Pretorius PJ
    Ann N Y Acad Sci; 2008 Aug; 1137():18-26. PubMed ID: 18837919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of circulating thyroid cancer cells in patients with thyroid microcarcinomas.
    Novosel T; Ritter HE; Gupta M; Harvey A; Mitchell J; Berber E; Siperstein A; Milas M
    Surgery; 2009 Dec; 146(6):1081-9. PubMed ID: 19958935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematogenous cytokeratin 20 mRNA detection has prognostic impact in oral squamous cell carcinoma: preliminary results.
    Toyoshima T; Vairaktaris E; Nkenke E; Schlegel KA; Neukam FW; Ries J
    Anticancer Res; 2009 Jan; 29(1):291-7. PubMed ID: 19331164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epithelial molecular markers in the peripheral blood of patients with colorectal cancer.
    Khair G; Monson JR; Greenman J
    Dis Colon Rectum; 2007 Aug; 50(8):1188-203. PubMed ID: 17436048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview of circulating nucleic acids in plasma/serum.
    Butt AN; Swaminathan R
    Ann N Y Acad Sci; 2008 Aug; 1137():236-42. PubMed ID: 18837954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.
    Schwarzenbach H; Alix-Panabières C; Müller I; Letang N; Vendrell JP; Rebillard X; Pantel K
    Clin Cancer Res; 2009 Feb; 15(3):1032-8. PubMed ID: 19188176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimization of purification of human cell-free mRNA from plasma.
    Dovc-Drnovsek T; Emersic B; Rozman P; Cerne D; Lukac-Bajalo J
    Ann N Y Acad Sci; 2008 Aug; 1137():125-9. PubMed ID: 18837935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fetal nucleic acids in maternal body fluids: an update.
    Bianchi DW; Wataganara T; Lapaire O; Tjoa ML; Maron JL; Larrabee PB; Johnson KL
    Ann N Y Acad Sci; 2006 Sep; 1075():63-73. PubMed ID: 17108193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of labour and placental separation on the shedding of syncytiotrophoblast microparticles, cell-free DNA and mRNA in normal pregnancy and pre-eclampsia.
    Reddy A; Zhong XY; Rusterholz C; Hahn S; Holzgreve W; Redman CW; Sargent IL
    Placenta; 2008 Nov; 29(11):942-9. PubMed ID: 18834630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gas chromatography/mass spectrometry in metabolic profiling of biological fluids.
    Pasikanti KK; Ho PC; Chan EC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(2):202-11. PubMed ID: 18479983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A diagnostic evaluation of serum human telomerase reverse transcriptase mRNA as a novel tumor marker for gynecologic malignancies.
    Miura N; Kanamori Y; Takahashi M; Sato R; Tsukamoto T; Takahashi S; Harada T; Sano A; Shomori K; Harada T; Kigawa J; Ito H; Terakawa N; Hasegawa J; Shiota G
    Oncol Rep; 2007 Mar; 17(3):541-8. PubMed ID: 17273731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Normalization of circulating nucleic acid results.
    Holford NC; Ramoutar A; Butt AN; Swaminathan R
    Ann N Y Acad Sci; 2008 Aug; 1137():112-8. PubMed ID: 18837933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral thyrotropin receptor mRNA as a novel marker for differentiated thyroid cancer diagnosis and surveillance.
    Barbosa GF; Milas M
    Expert Rev Anticancer Ther; 2008 Sep; 8(9):1415-24. PubMed ID: 18759693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SCG3 transcript in peripheral blood is a prognostic biomarker for REST-deficient small cell lung cancer.
    Moss AC; Jacobson GM; Walker LE; Blake NW; Marshall E; Coulson JM
    Clin Cancer Res; 2009 Jan; 15(1):274-83. PubMed ID: 19118055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.